miRNA polymorphisms and risk of premature coronary artery disease.


Journal

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
ISSN: 2241-5955
Titre abrégé: Hellenic J Cardiol
Pays: Netherlands
ID NLM: 101257381

Informations de publication

Date de publication:
Historique:
received: 07 10 2019
revised: 19 01 2020
accepted: 22 01 2020
pubmed: 25 2 2020
medline: 19 8 2021
entrez: 25 2 2020
Statut: ppublish

Résumé

Several microRNA (miRNA) polymorphisms have been associated with susceptibility to specific health disorders, including cardiovascular diseases. The aim of the present study was to investigate whether four well-studied miRNA polymorphisms in non-Caucasian populations, namely miR146a G>C (rs2910164), miR149 C>T (rs2292832), miR196a2 C>T (rs11614913) and miR499 A>G (rs3746444), contribute to the risk for the development of premature Coronary Artery Disease (CAD) in the Greek population. We used a case-control study to examine these associations in 400 individuals: 200 CAD patients [including a subgroup of myocardial infraction (MI) patients] and 200 healthy controls, all of Greek origin. MiRNA polymorphisms were genotyped using three different assays: Polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP), High resolution Melting (HRM) and Sanger sequencing. Two of these polymorphisms, miR196a2 C>T (rs11614913) and miR499 A>G (rs3746444) were found to be strongly associated with increased risk for CAD (p=0.0388 and p=0.0013, respectively) and for MI (p=0.0281 and p=0.0273, respectively). Furthermore, miR146C-miR149C-miR196T-miR499G allele combination appeared to be significantly related to CAD (p=0.0185) and MI (p=0.0337) prevalence. Our results suggest that at least two of the studied polymorphisms, miR196a2 C>T (rs11614913) and miR499 A>G (rs3746444), as well as the miR146C-miR149C-miR196T-miR499G allele combination could represent useful biomarkers of CAD and/or MI susceptibility in the Greek population. These special genetic characteristics, in combination with environmental factors and personal habits, might contribute to CAD and/or MI prevalence.

Identifiants

pubmed: 32092393
pii: S1109-9666(20)30031-2
doi: 10.1016/j.hjc.2020.01.005
pii:
doi:

Substances chimiques

MIRN499 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-284

Informations de copyright

Copyright © 2020 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors have no conflict of interest to declare.

Auteurs

Konstantinos Agiannitopoulos (K)

Division of Genetics & Biotechnology, Department of Biology, National & Kapodistrian University of Athens, Athens, Greece. Electronic address: kagiannitopoulos@yahoo.gr.

Pinelopi Samara (P)

Division of Genetics & Biotechnology, Department of Biology, National & Kapodistrian University of Athens, Athens, Greece.

Miranta Papadopoulou (M)

Division of Genetics & Biotechnology, Department of Biology, National & Kapodistrian University of Athens, Athens, Greece.

Astradeni Efthymiadou (A)

Division of Genetics & Biotechnology, Department of Biology, National & Kapodistrian University of Athens, Athens, Greece.

Eirini Papadopoulou (E)

Genekor M.S.A, Athens, Greece.

Georgios N Tsaousis (GN)

Genekor M.S.A, Athens, Greece.

George Mertzanos (G)

Department of Cardiology, "KAT" General Hospital, Athens, Greece.

Dimitrios Babalis (D)

Department of Cardiology, "KAT" General Hospital, Athens, Greece.

Klea Lamnissou (K)

Division of Genetics & Biotechnology, Department of Biology, National & Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH